Clinical Trials Browser

INDUSTRY × EC regimen × 90 days × Clear all

NCT07625644 2026-06-04

Evaluate BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer

Phase 3 Not yet recruiting

Lung Neoplasms, Carcinoma, Small Cell, Small Cell Lung Carcinoma